Impact News +++ Hap Chan, a Leading Chinese Restaurant Chain in the Philippines, Makes Repeat Order and Adopts Beyond... (GlobeNewswire EN) +++ BEYOND OIL Aktie -3,60%

OPKO HEALTH Aktie

>OPKO HEALTH Aktienkurs

1.14 EUR -0.1% (Tradegate)

Ask: 1.133 EUR / 8900 Stück

Bid: 1.114 EUR / 9000 Stück

Tagesumsatz: 2730 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

OPKO HEALTH Aktie über LYNX handeln

Intraday

1 Jahr

>OPKO HEALTH Performance

1 Woche: -2,9%

1 Monat: -14,4%

3 Monate: -6,5%

6 Monate: -5,8%

1 Jahr: -27,3%

laufendes Jahr: -21,6%

>OPKO HEALTH Aktie

Name:

OPKO HEALTH INC. DL-,01

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US68375N1037 / A0MUUJ

Symbol/ Ticker:

XCY (Frankfurt) / OPK (NASDAQ)

Kürzel:

FRA:XCY, ETR:XCY, XCY:GR, NASDAQ:OPK

Index:

Webseite:

https://www.opko.com/

Profil:

Opko Health Inc. is a diversified healthcare compa..
>Volltext..

Marktkapitalisierung:

872.51 Mio. EUR

Unternehmenswert:

855.64 Mio. EUR

Umsatz:

557.01 Mio. EUR

EBITDA:

-104.52 Mio. EUR

Nettogewinn:

-156.53 Mio. EUR

Gewinn je Aktie:

-0.21 EUR

Schulden:

343.06 Mio. EUR

Liquide Mittel:

360.21 Mio. EUR

Operativer Cashflow:

-170.94 Mio. EUR

Bargeldquote:

2.45

Umsatzwachstum:

-14.37%

Gewinnwachstum:

-27.99%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

1 Insider kaufte innerhalb der letzten 30 Tage Aktien im Wert von 1.651.457 USD.

Suchwörter:

OPKO HEALTH

Letzte Datenerhebung:

20.11.25

>OPKO HEALTH Kennzahlen

Aktien/ Unternehmen:

Aktien: 767.7 Mio. St.

Frei handelbar: 51.33%

Leerverk. Aktien: 4.13%

Rückkaufquote: 4.98%

Mitarbeiter: 2997

Umsatz/Mitarb.: 0.21 Mio. EUR

Analysten:

Analystenrating: Strong buy

Kursziel: 177.99%

Bewertung:

KGV: -

KGV lG: -

KUV: 1.56

KBV: 0.76

PEG-Ratio: -0.19

EV/EBITDA: -

Rentabilität:

Bruttomarge: 22.96%

Gewinnmarge: -28.1%

Operative Marge: -33.3%

Managementeffizenz:

Gesamtkaprendite: -8.49%

Eigenkaprendite: -13.32%

>OPKO HEALTH Peer Group

Es sind 599 Aktien bekannt.

>OPKO HEALTH Chart & Kurs - NASDAQ

>OPKO HEALTH News

20.11.25 - 02:02	Insiderhandel: CEO & Chairman kauft Aktien von Opko Health im Wert von 759117 USD (Insiderkauf)
	Frost, Phillip Md Et Al - Vorstand - Tag der Transaktion: 2025-11-19...

19.11.25 - 22:09

OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire EN)

MIAMI, Nov. 19, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Piper Sandler 37th Annual Healthcare Conference, being held December 2-4, 2025 at the Lotte New York Palace Hotel in New York City. Management will be holding one-on-one meetings with investors and will be participating in a fireside discussion on Wednesday, December 3rd at 12:00 p.m. Eastern time....

19.11.25 - 00:02	Insiderhandel: CEO & Chairman kauft Aktien von Opko Health im Wert von 678905 USD (Insiderkauf)
	Frost, Phillip Md Et Al - Vorstand - Tag der Transaktion: 2025-11-18...

01.11.25 - 02:01	Insiderhandel: CEO & Chairman kauft Aktien von Opko Health im Wert von 213435 USD (Insiderkauf)
	Frost, Phillip Md Et Al - Vorstand - Tag der Transaktion: 2025-10-31...

30.10.25 - 18:45	OPK Q3 Earnings Beat Estimates, Sales Miss, Gross Margin Expands (Zacks)
	OPKO Health's Q3 earnings top estimates despite lower sales. Cost cuts and product strength boost margins and operating income....

30.10.25 - 00:45	Compared to Estimates, OPKO Health (OPK) Q3 Earnings: A Look at Key Metrics (Zacks)
	While the top- and bottom-line numbers for OPKO Health (OPK) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....

30.10.25 - 00:00	OPKO Health (OPK) Q3 Earnings Surpass Estimates (Zacks)
	OPKO Health (OPK) delivered earnings and revenue surprises of +250.00% and -3.44%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?...

29.10.25 - 21:06	OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results (GlobeNewswire EN)
	Conference call begins at 4:30 p.m. Eastern time today Conference call begins at 4:30 p.m. Eastern time today...

29.10.25 - 14:36	Regeneron Partners With ModeX Therapeutics To Discover And Develop Multispecific Antibodies (AFX)
	WASHINGTON (dpa-AFX) - Wednesday, Regeneron Pharmaceuticals, Inc. (REGN) and ModeX Therapeutics Inc., an OPKO Health company (OPK) entered into a license and collaboration agreement to discover an......

28.10.25 - 22:42	OPKO Health Q3 Earnings Preview (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

23.10.25 - 21:15	Here′s Why You Should Add OPKO Health Stock to Your Portfolio (Zacks)
	OPK benefits from RAYALDEE momentum, strategic deals and advancing trials amid stiff competition and dependence risks....

22.10.25 - 22:09

OPKO Health to Report Third Quarter 2025 Financial Results on October 29 (GlobeNewswire EN)

MIAMI, Oct. 22, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and nine months ended September 30, 2025 after the close of the U.S. financial markets on Wednesday, October 29, 2025. OPKO's senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on October 29th beginning at 4:30 p.m. Eastern time....

16.09.25 - 03:48	Labcorp Completes $225 Mln Acquisition Of BioReference Health′s Oncology Testing Business (AFX)
	WASHINGTON (dpa-AFX) - Labcorp (LH) and OPKO Health, Inc. announced the completion of Labcorp's acquisition of select BioReference Health assets focused on oncology and oncology-related clinical t......

15.09.25 - 14:33	Labcorp Completes Acquisition of Select Assets of BioReference Health′s Innovative Oncology and Related Clinical Testing Services Businesses (PR Newswire)
	BURLINGTON, N.C. and MIAMI, Sept. 15, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today the completion of Labcorp's......

11.09.25 - 19:45	Here′s Why You Should Retain OPKO Health Stock in Your Portfolio (Zacks)
	OPK benefits from RAYALDEE momentum, strategic deals and advancing trials amid stiff competition and dependence risks....

09.08.25 - 03:01	Insiderhandel: CEO & Chairman kauft Aktien von Opko Health im Wert von 891000 USD (Insiderkauf)
	Frost, Phillip Md Et Al - Vorstand - Tag der Transaktion: 2025-08-08...

07.08.25 - 15:00	OPKO Health (OPK) Q2 2025 Earnings Call Transcript (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

01.08.25 - 23:25	Opko Health (OPK) Q2 Revenue Falls 14% (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

01.08.25 - 19:45	OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands (Zacks)
	OPKO Health reports wider-than-expected second-quarter 2025 loss and revenue decline, but gross margin expands and product sales remain stable....

01.08.25 - 03:24	OPKO Health outlines $640M–$660M 2025 revenue target as BioReference sale and pipeline advances drive profitability push (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Der Unterschied zwischen dem richtigen Wort und dem beinahe richtigen ist derselbe wie zwischen einem Blitz und einem Glühwürmchen. - Mark Twain

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram